Literature DB >> 25565192

Chronic congestive heart failure in infancy and childhood: new aspects of diagnosis and treatment.

A A Schmaltz1.   

Abstract

Congestive heart failure (CHF) is the inability of the heart to meet the metabolic demands of the body. As a disease of the advanced age with a frequency of 1-2% of the population it is rare in infancy and childhood. The incidence ranges from 2.95 (in all US children's hospitals) to 23.2 (University's Childrens Hospital Essen) on 1 000 discharges. Among the diagnostic procedures echocardiography is the primary modality of imaging. Tei-index and tissue-Doppler are more sensitive parameters for LV-dysfunction. BNP/NT-proBNP are age-dependent and can guide the long-term therapy. Treatment in childhood does not differ basically from that in adulthood, recommended by several guidelines, but data regarding the various substances - outlined in detail - are very limited. Here a big work has to be done in future! © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25565192     DOI: 10.1055/s-0034-1389974

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  4 in total

Review 1.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

Review 2.  "Nihilism" of chronic heart failure therapy in children and why effective therapy is withheld.

Authors:  Dietmar Schranz; Norbert F Voelkel
Journal:  Eur J Pediatr       Date:  2016-02-19       Impact factor: 3.183

3.  Heart Failure Induced by Perinatal Ablation of Cardiac Myosin Light Chain Kinase.

Authors:  Yasmin F K Islam; Ryan Joseph; Rajib R Chowdhury; Robert H Anderson; Hideko Kasahara
Journal:  Front Physiol       Date:  2016-10-26       Impact factor: 4.566

4.  A retrospective study on the short-term effect of high-dose spironolactone (80 mg/d) on chronic congestive heart failure.

Authors:  Pan Tao; Tu Zhitao; Liu Jiming
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.